Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma.
Azcue P, Guerrero Setas D, Encío I, Ibáñez-Beroiz B, Mercado M, Vera R, Gómez-Dorronsoro ML. Azcue P, et al. Among authors: guerrero setas d. Cancers (Basel). 2021 Nov 24;13(23):5909. doi: 10.3390/cancers13235909. Cancers (Basel). 2021. PMID: 34885019 Free PMC article.
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures.
Arechederra M, Rullán M, Amat I, Oyon D, Zabalza L, Elizalde M, Latasa MU, Mercado MR, Ruiz-Clavijo D, Saldaña C, Fernández-Urién I, Carrascosa J, Jusué V, Guerrero-Setas D, Zazpe C, González-Borja I, Sangro B, Herranz JM, Purroy A, Gil I, Nelson LJ, Vila JJ, Krawczyk M, Zieniewicz K, Patkowski W, Milkiewicz P, Cubero FJ, Alkorta-Aranburu G, G Fernandez-Barrena M, Urman JM, Berasain C, Avila MA. Arechederra M, et al. Among authors: guerrero setas d. Gut. 2022 Jun;71(6):1141-1151. doi: 10.1136/gutjnl-2021-325178. Epub 2021 Jul 20. Gut. 2022. PMID: 34285068 Free PMC article.
EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas.
Perez-Janices N, Blanco-Luquin I, Tuñón MT, Barba-Ramos E, Ibáñez B, Zazpe-Cenoz I, Martinez-Aguillo M, Hernandez B, Martínez-Lopez E, Fernández AF, Mercado MR, Cabada T, Escors D, Megias D, Guerrero-Setas D. Perez-Janices N, et al. Among authors: guerrero setas d. Oncotarget. 2015 Jan 1;6(1):368-80. doi: 10.18632/oncotarget.2745. Oncotarget. 2015. PMID: 25621889 Free PMC article.
Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix.
Mendaza S, Fernández-Irigoyen J, Santamaría E, Arozarena I, Guerrero-Setas D, Zudaire T, Guarch R, Vidal A, Salas JS, Matias-Guiu X, Ausín K, Gil C, Hernández-Alcoceba R, Martín-Sánchez E. Mendaza S, et al. Among authors: guerrero setas d. Cancers (Basel). 2021 Apr 6;13(7):1739. doi: 10.3390/cancers13071739. Cancers (Basel). 2021. PMID: 33917510 Free PMC article.
A case of intraductal carcinoma with pleomorphic cells.
Cordoba A, Guerrero-Setas D, Vicente F, Mercado MR, Rodriguez I, Martinez-Peñuela JM. Cordoba A, et al. Among authors: guerrero setas d. Pathol Int. 2012 Jul;62(7):511-2. doi: 10.1111/j.1440-1827.2012.02818.x. Pathol Int. 2012. PMID: 22726073 No abstract available.
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Vicente-García F, Blanco-Luquin I, De La Cruz S, Aramendia A, Guerrero-Setas D. Martín-Sánchez E, et al. Among authors: guerrero setas d. Clin Epigenetics. 2017 Jan 24;9:7. doi: 10.1186/s13148-016-0309-z. eCollection 2017. Clin Epigenetics. 2017. PMID: 28149335 Free PMC article.
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.
Mendaza S, Fernández-Irigoyen J, Santamaría E, Zudaire T, Guarch R, Guerrero-Setas D, Vidal A, Santos-Salas J, Matias-Guiu X, Ausín K, Díaz de Cerio MJ, Martín-Sánchez E. Mendaza S, et al. Among authors: guerrero setas d. Int J Mol Sci. 2020 Mar 19;21(6):2125. doi: 10.3390/ijms21062125. Int J Mol Sci. 2020. PMID: 32204550 Free PMC article.
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Blanco-Luquin I, Córdoba A, Vicente-García F, Pérez-Janices N, Escors D, Megías D, López-Serra P, Esteller M, Illarramendi JJ, Guerrero-Setas D. Martín-Sánchez E, et al. Among authors: guerrero setas d. Oncotarget. 2017 Feb 28;8(9):15789-15801. doi: 10.18632/oncotarget.15004. Oncotarget. 2017. PMID: 28178655 Free PMC article.
27 results